Table 3.
Characteristics of patients (P-value1) | ACA+/SS (n = 20) [%] |
SSc/(+) sicca (n = 31) [%] |
SSc/(-) sicca (n = 20) [%] | ACA-/SS (n = 61) [%] |
---|---|---|---|---|
Sex(0.558) | ||||
female | 20 [100.0] | 28 [90.3] | 19 [95.0] | 57 [93.4] |
male | 0 [0.0] | 3 [9.7] | 1 [5.0] | 4 [6.6] |
P-values2 | 0.271 | 1.000 | 0.567 | |
Smoking (0.603) | 4 [20.0] | 5 [16.1] | 2 [10.0] | 14 [23.0] |
P --values2 | 0.703 | 0.661 | 1.000 | |
Anti-Ro (<0.0001) | 6 [30.0] | 4 [12.9] | 0 [0.0] | 43 [70.5] |
P-values2 | 0.163 | 0.020 | 0.003 | |
Anti-La (<0.0001) | 3 [15.0] | 2 [6.5] | 0 [0.0] | 25 [41.0] |
P-values2 | 0.369 | 0.231 | 0.056 | |
ANA (0.006) | 20 [100.0] | 31 [100.0] | 20 [100.0] | 51 [83.6] |
P-values2 | - | - | 0.060 | |
Anti-U1RNP (0.558) | 0 [0.0] | 3 [9.7] | 1 [5.0] | 4 [6.6] |
P-values2 | 0.271 | 1.000 | 0. 567 | |
Anti-Sm (0.721) | 0 [0.0] | 1 [3.2] | 0 [0.0] | 2 [3.3] |
P-values2 | 1.000 | - | 1.000 | |
Anti-Scl70 (0.172) | 0 [0.0] | 2 [6.5] | 1 [5.0] | 0 [0.0] |
P-values2 | 0.514 | 1.000 | - | |
Th. Hashimoto (0.023) | 1 [5.0] | 4 [12.9] | 0 [0.0] | 15 [24.6] |
P-values2 | 0.636 | 1.000 | 0.102 | |
Autoim. Hepatitis (-) | 0 [0.0] | 0 [0.0] | 0 [0.0] | 0 [0.0] |
P-values2 | - | - | - | |
Atr. gastritis (0.422) | 2 [10.0] | 2 [6.5] | 0 [0.0] | 2 [3.3] |
P-values2 | 0.640 | 0.487 | 0.254 | |
PBC (0.209) | 3 [15.0] | 3 [9.7] | 0 [0.0] | 3 [4.9] |
P-values2 | 0.668 | 0.231 | 0.157 | |
Celiac (0.209) | 0 [0.0] | 0 [0.0] | 0 [0.0] | 1 [1.6] |
P-values2 | - | - | 1.000 | |
Lymphoma (0.476) | 0 [0.0] | 2 [6.5] | 0 [0.0] | 2 [3.3] |
P-values2 | 0.514 | - | 1.000 | |
Death (0.059) | 0 [0.0] | 3 [9.7] | 1 [5.0] | 0 [0.0] |
P-values2 | 0.271 | 1.000 | - |
1 Overall P-value from the Chi Square test of independence (significance < 0.05).
2 P-values from the Fisher's exact test comparing the first group with each of the other three groups
PBC, primary biliary cirrhosis